CA
ABBV icon

CSM Advisors’s AbbVie ABBV Stock Holding History

CSM Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1M Buy
143,403
+17,383
+14% +$3.74M 0.77% 29
2026
Q1 		$27.4M Buy
126,020
+17,794
+16% +$3.95M 0.67% 35
2025
Q4 		$24.7M Buy
108,226
+8,388
+8% +$1.91M 0.67% 41
2025
Q3 		$23.1M Buy
99,838
+3,171
+3% +$646K 0.65% 43
2025
Q2 		$17.9M Buy
+96,667
New +$18M 0.52% 58

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSM Advisors's ABBV Position: Q2 2026 in Review

CSM Advisors increased its AbbVie (ABBV) stake by 14% in Q2 2026, buying an estimated $3.74M and bringing the position to 143,403 shares worth $36.1M. The position accounts for 0.77% of the portfolio, ranked #29.

CSM Advisors first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • CSM Advisors held 143,403 shares of AbbVie worth $36.1M as of Q2 2026.
  • CSM Advisors bought 17,383 AbbVie shares in Q2 2026, an estimated $3.74M.
  • AbbVie made up 0.77% of CSM Advisors's portfolio in Q2 2026, its #29 holding.
  • CSM Advisors first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CSM Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.